Closing Our Series of Posts on AI in the Pharmaceuticals Industry

We are closing our series of posts AI in Pharma with the profile of Merck. It’s been a pleasure to dive into the industry and see how things are changing. Pharmaceutical companies are embracing AI fully, acquiring companies, signing partnerships, discovering new drugs in record time, reinventing their relationship with their customers, and facing an ever-changing regulatory environment.This Serie has been a success and I thank you all readers, and commenters for your support. Much appreciated! Melvine

Sign up to read this post
Join Now
Previous
Previous

Melvine's AI Analysis # 48 - 🚀 AI Revolution at Merck: Transforming Pharma from Lab to Patient

Next
Next

Melvine's AI Analysis # 49 - 🚀Harnessing AI and Gen AI at Blackstone: Opportunities, Challenges, and the Road Ahead